Christopher J Morabito
Hoofd Techniek/Wetenschap/O&O bij ASTRIA THERAPEUTICS, INC.
Vermogen: - $ op 30-04-2024
Actieve functies van Christopher J Morabito
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 15-07-2022 | - |
Loopbaan van Christopher J Morabito
Eerdere bekende functies van Christopher J Morabito
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 10-05-2021 | 13-07-2022 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-10-2016 | 01-07-2020 |
| MERCK & CO., INC. | Directeur/Bestuurslid | 01-10-2010 | 01-04-2014 |
Cardurion Pharmaceuticals LLC
 Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Christopher J Morabito
| Franklin & Marshall College | Undergraduate Degree |
| Penn State Hershey College of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Japan | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Cardurion Pharmaceuticals LLC
Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Health Technology |
